Effective systemic therapy for the treatment of stage III melanoma has emerged. Whether this influences treatment choice in stage III melanoma patients with in-transit metastases is the subject of this review.
Dirk J. Grünhagen, MD, PhD
Advertisement
Articles by Dirk J. Grünhagen, MD, PhD
Advertisement
Latest Updated Articles
Isolated Limb Perfusion for Stage III Melanoma: Does It Still Have a Role in the Present Era of Effective Systemic Therapy?Published: December 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
3
FDA Grants Regular Approval to Rucaparib in Metastatic CRPC
4
Pelareorep Exhibits Activity in Second-Line KRAS-Mutated Metastatic CRC
5